NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Jun 14 2021

· Issued by NATCO Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-14-2021-10

Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "NATCO receives approval for Carfilzomib Vials ANDA (generic for KYPROLIS��) in the US market".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases